Clinical Trials Logo

Clinical Trial Summary

THis study is intended to provide contemporary data on the burden of disease in patients 1 to 3 years post-MI, including a description of patient characteristics, current treatment patterns, rate of major CV events, and healthcare resource utilization in a 'real world' patient population at high atherothrombotic risk.


Clinical Trial Description

TIGRIS is a multinational, multi-centre, observational, prospective, longitudinal cohort study which will include stable CAD patients with history of MI 1-3 years ago and high risk of developing atherothrombotic events in a real world setting. The follow-up period is 3 years.

Patients will undergo clinical assessments and receive standard medical care as determined by the treating physician. Patients will not receive experimental intervention or experimental treatment as a consequence of their participation in the study. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01866904
Study type Observational
Source AstraZeneca
Contact
Status Terminated
Phase
Start date June 19, 2013
Completion date March 31, 2017